An American Heart Association scientific statement outlines updated recommendations for the screening, diagnosis, and management of pediatric hypertriglyceridemia, emphasizing its association with obesity, insulin resistance, metabolic syndrome, and long-term atherosclerotic cardiovascular disease risk. The statement provides guidance on fasting and nonfasting lipid assessment, risk stratification, lifestyle-first interventions, and pharmacologic therapy for severe elevations to reduce pancreatitis risk and mitigate future cardiometabolic complications.

Source: Arteriosclerosis, Thrombosis, and Vascular Biology